[Letter: Lipid lowering drugs].
D001161:Arteriosclerosis / Q000188:drug therapy*; D002792:Cholestyramine Resin / Q000009:adverse effects; D002994:Clofibrate / Q000009:adverse effects; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000009:adverse effects; D013974:Thyroxine / Q000009:adverse effects
D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D002994:Clofibrate; D013974:Thyroxine
Lipidsenkende Arzneimittel.